Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

ASCO 2021 Highlights

Tecentriq Slashes Risk of Cancer Progression, Death in Patients with Early-Stage Non–Small-Cell Lung Cancer and PD-L1 Expression

Bavencio Leads to Long-Term Survival in Patients with Metastatic Merkel-Cell Carcinoma

Libtayo Safe and Effective in Immunocompromised Patients with Advanced Skin Cancer

¹⁷⁷Lu-PSMA-617, Novel Targeted Therapy, Extends Survival in Men with Metastatic Prostate Cancer

Increasing PSA Screening in Black Men Will Improve the Diagnosis of Prostate Cancer and Reduce Deaths

Challenges and Progress in the Treatment of Patients with High-Risk, Relapsed Multiple Myeloma

Patient-Reported Outcomes and Vision-Related Symptoms Can Guide the Dosing of Blenrep in Patients with Relapsed or Refractory Multiple Myeloma

New Approaches to Systemic Therapy for Patients with Stage III Melanoma

Adding Venclexta to Revlimid and Rituxan Leads to Undetectable Cancer in Mantle-Cell Lymphoma

Hot Topics from the 2021 American Society of Clinical Oncology Conference

Page 1 of 2